1. Home
  2. ACXP vs ULY Comparison

ACXP vs ULY Comparison

Compare ACXP & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • ULY
  • Stock Information
  • Founded
  • ACXP 2017
  • ULY 2013
  • Country
  • ACXP United States
  • ULY United States
  • Employees
  • ACXP N/A
  • ULY N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • ULY
  • Sector
  • ACXP Health Care
  • ULY
  • Exchange
  • ACXP Nasdaq
  • ULY Nasdaq
  • Market Cap
  • ACXP 6.8M
  • ULY 5.8M
  • IPO Year
  • ACXP 2021
  • ULY N/A
  • Fundamental
  • Price
  • ACXP $6.30
  • ULY $2.80
  • Analyst Decision
  • ACXP Strong Buy
  • ULY Strong Buy
  • Analyst Count
  • ACXP 3
  • ULY 2
  • Target Price
  • ACXP $143.67
  • ULY $11.50
  • AVG Volume (30 Days)
  • ACXP 1.6M
  • ULY 990.9K
  • Earning Date
  • ACXP 11-12-2025
  • ULY 11-12-2025
  • Dividend Yield
  • ACXP N/A
  • ULY N/A
  • EPS Growth
  • ACXP N/A
  • ULY N/A
  • EPS
  • ACXP N/A
  • ULY N/A
  • Revenue
  • ACXP N/A
  • ULY $131,235,000.00
  • Revenue This Year
  • ACXP N/A
  • ULY N/A
  • Revenue Next Year
  • ACXP N/A
  • ULY $20.23
  • P/E Ratio
  • ACXP N/A
  • ULY N/A
  • Revenue Growth
  • ACXP N/A
  • ULY N/A
  • 52 Week Low
  • ACXP $3.80
  • ULY $2.63
  • 52 Week High
  • ACXP $39.20
  • ULY $17.99
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 54.01
  • ULY 37.14
  • Support Level
  • ACXP $6.24
  • ULY $2.63
  • Resistance Level
  • ACXP $6.80
  • ULY $3.07
  • Average True Range (ATR)
  • ACXP 0.61
  • ULY 0.27
  • MACD
  • ACXP -0.13
  • ULY 0.02
  • Stochastic Oscillator
  • ACXP 3.16
  • ULY 17.28

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: